德爾卡特系統公司
US ˙ NasdaqCM ˙ US24661P8077

簡介

本頁面提供了有關 Gabriel Leung 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Gabriel Leung已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:NVCR / NovoCure Limited Director 101,109
US:PTX / Pernix Therapeutics Holdings, Inc. Director 25,000
US:AMRI / Albany Molecular Research, Inc. Director 6,881
US:DCTH / Delcath Systems, Inc. Director 21,485
如何解讀這些圖表

以下圖表顯示了在Gabriel Leung進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

DCTH / Delcath Systems, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 DCTH / Delcath Systems, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2012-06-15 DCTH LEUNG GABRIEL 7,500 1.5682 19 613.9503 11,762 115 591.36 -525 -4.47

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

DCTH / Delcath Systems, Inc. Insider Trades
DCTH / Delcath Systems, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 DCTH / Delcath Systems, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

DCTH / Delcath Systems, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Gabriel Leung 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-06-05 2026-06-03 4 NVCR NovoCure Ltd
Ordinary Shares
A - Award 11,610 101,109 12.97
2026-06-03 2026-06-02 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -2,945 89,499 -3.19 15.77 -46,445 1,411,462
2025-06-06 2025-06-04 4 NVCR NovoCure Ltd
Ordinary Shares
A - Award 11,215 92,444 13.81
2025-06-04 2025-06-03 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -999 81,229 -1.21 17.31 -17,297 1,406,448
2024-06-06 2024-06-05 4 NVCR NovoCure Ltd
Restricted Stock Units
A - Award 4,053 83,192 5.12
2024-06-06 2024-06-04 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -964 78,175 -1.22 23.89 -23,025 1,867,218
2023-06-09 2023-06-07 4 NVCR NovoCure Ltd
Restricted Stock Units
A - Award 3,853 79,139 5.12
2022-06-10 2022-06-08 4 NVCR NovoCure Ltd
Restricted Stock Units
A - Award 2,427 75,286 3.33
2021-08-06 2021-08-05 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -1,000 2,345 -29.90
2021-08-06 2021-08-05 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -1,000 72,859 -1.35 152.50 -152,500 11,110,998
2021-08-06 2021-08-05 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 1,000 73,859 1.37 31.45 31,450 2,322,866
2021-07-08 2021-07-06 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -1,000 3,345 -23.01
2021-07-08 2021-07-06 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -1,000 72,859 -1.35 183.54 -183,540 13,372,541
2021-07-08 2021-07-06 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 1,000 73,859 1.37 31.45 31,450 2,322,866
2021-06-11 2021-06-09 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
A - Award 1,499 1,499
2021-06-11 2021-06-09 4 NVCR NovoCure Ltd
Restricted Stock Units
A - Award 814 72,859 1.13
2021-06-08 2021-06-07 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -1,000 4,345 -18.71
2021-06-08 2021-06-07 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -1,000 72,045 -1.37 204.55 -204,550 14,736,805
2021-06-08 2021-06-07 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 1,000 73,045 1.39 31.45 31,450 2,297,265
2021-05-06 2021-05-05 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -1,000 5,345 -15.76
2021-05-06 2021-05-05 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -1,000 72,045 -1.37 199.67 -199,670 14,385,225
2021-05-06 2021-05-05 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 1,000 73,045 1.39 31.45 31,450 2,297,265
2021-04-15 2021-04-13 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -6,000 6,345 -48.60
2021-04-15 2021-04-13 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -2,500 72,045 -3.35 200.00 -500,000 14,409,000
2021-04-15 2021-04-13 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -3,500 74,545 -4.48 198.01 -693,035 14,760,655
2021-04-15 2021-04-13 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 6,000 78,045 8.33 31.45 188,700 2,454,515
2020-09-16 2020-09-15 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -7,392 0 -100.00
2020-09-16 2020-09-15 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -2,173 0 -100.00
2020-09-16 2020-09-15 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -7,392 72,045 -9.31 100.00 -739,200 7,204,500
2020-09-16 2020-09-15 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 7,392 79,437 10.26 7.48 55,292 594,189
2020-09-16 2020-09-15 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -2,173 72,045 -2.93 100.00 -217,300 7,204,500
2020-09-16 2020-09-15 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 2,173 74,218 3.02 7.48 16,254 555,151
2020-09-16 2020-09-14 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -10,000 2,173 -82.15
2020-09-16 2020-09-14 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -10,000 72,045 -12.19 95.00 -950,000 6,844,275
2020-09-16 2020-09-14 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 10,000 82,045 13.88 7.48 74,800 613,697
2020-09-11 2020-09-10 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -10,000 12,173 -45.10
2020-09-11 2020-09-10 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -10,000 72,045 -12.19 90.00 -900,000 6,484,050
2020-09-11 2020-09-10 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 10,000 82,045 13.88 7.48 74,800 613,697
2020-09-11 2020-09-09 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -9,114 0 -100.00
2020-09-11 2020-09-09 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -100 72,045 -0.14 86.06 -8,606 6,200,193
2020-09-11 2020-09-09 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -9,014 72,145 -11.11 85.39 -769,687 6,160,317
2020-09-11 2020-09-09 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 9,114 81,159 12.65 7.03 64,071 570,548
2020-09-04 2020-09-02 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -100 9,114 -1.09
2020-09-04 2020-09-02 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -100 72,045 -0.14 85.00 -8,500 6,123,825
2020-09-04 2020-09-02 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 100 72,145 0.14 7.03 703 507,179
2020-08-27 2020-08-25 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -7,112 0 -100.00
2020-08-27 2020-08-25 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -7,112 72,045 -8.98 80.13 -569,892 5,773,038
2020-08-27 2020-08-25 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 7,112 79,157 9.87 7.03 49,997 556,474
2020-08-03 2020-07-30 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -7,112 7,112 -50.00
2020-08-03 2020-07-30 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -7,112 72,045 -8.98 75.00 -533,400 5,403,375
2020-08-03 2020-07-30 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 7,112 79,157 9.87 7.03 49,997 556,474
2020-07-23 2020-07-22 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -9,500 9,214 -50.76
2020-07-23 2020-07-22 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -4,504 72,045 -5.88 67.46 -303,844 4,860,228
2020-07-23 2020-07-22 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -4,573 76,549 -5.64 66.75 -305,257 5,109,799
2020-07-23 2020-07-22 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -423 81,122 -0.52 65.48 -27,696 5,311,463
2020-07-23 2020-07-22 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 9,500 81,545 13.19 7.03 66,785 573,261
2020-07-23 2020-07-21 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -500 18,714 -2.60
2020-07-23 2020-07-21 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -500 72,045 -0.69 65.07 -32,536 4,688,184
2020-07-23 2020-07-21 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 500 72,545 0.69 7.03 3,515 509,991
2020-06-12 2020-06-10 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
A - Award 5,101 5,101
2020-06-12 2020-06-10 4 NVCR NovoCure Ltd
Restricted Stock Units
A - Award 2,541 72,045 3.66
2019-11-26 2019-11-25 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -20,000 19,214 -51.00
2019-11-26 2019-11-25 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -20,000 69,504 -22.35 95.00 -1,900,000 6,602,880
2019-11-26 2019-11-25 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 20,000 89,504 28.78 7.03 140,600 629,213
2019-11-22 2019-11-20 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -20,000 39,214 -33.78
2019-11-22 2019-11-20 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -20,000 69,504 -22.35 90.00 -1,800,000 6,255,360
2019-11-22 2019-11-20 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 20,000 89,504 28.78 7.03 140,600 629,213
2019-11-19 2019-11-18 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -10,000 59,214 -14.45
2019-11-19 2019-11-18 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -10,000 69,504 -12.58 85.00 -850,000 5,907,840
2019-11-19 2019-11-18 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 10,000 79,504 14.39 7.03 70,300 558,913
2019-11-19 2019-11-15 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,257 69,214 -7.06
2019-11-19 2019-11-15 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -4,743 0 -100.00
2019-11-19 2019-11-15 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -354 69,504 -0.51 84.00 -29,737 5,838,614
2019-11-19 2019-11-15 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -3,203 69,858 -4.38 83.51 -267,486 5,833,911
2019-11-19 2019-11-15 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -1,700 73,061 -2.27 82.52 -140,282 6,028,921
2019-11-19 2019-11-15 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 5,257 74,761 7.56 7.03 36,957 525,570
2019-11-19 2019-11-15 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -443 69,504 -0.63 84.02 -37,220 5,839,657
2019-11-19 2019-11-15 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -2,800 69,947 -3.85 83.50 -233,803 5,840,644
2019-11-19 2019-11-15 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -1,500 72,747 -2.02 82.55 -123,825 6,005,265
2019-11-19 2019-11-15 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 4,743 74,247 6.82 3.44 16,316 255,410
2019-11-13 2019-11-11 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,000 4,743 -51.32
2019-11-13 2019-11-11 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -5,000 69,504 -6.71 79.57 -397,850 5,530,433
2019-11-13 2019-11-11 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 5,000 74,504 7.19 3.44 17,200 256,294
2019-10-15 2019-10-10 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,000 9,743 -33.91
2019-10-15 2019-10-10 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -5,000 69,504 -6.71 72.28 -361,400 5,023,749
2019-10-15 2019-10-10 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 5,000 74,504 7.19 3.44 17,200 256,294
2019-09-12 2019-09-10 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,000 14,743 -25.33
2019-09-12 2019-09-10 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -5,000 69,504 -6.71 76.63 -383,150 5,326,092
2019-09-12 2019-09-10 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 5,000 74,504 7.19 3.44 17,200 256,294
2019-08-14 2019-08-12 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,000 19,743 -20.21
2019-08-14 2019-08-12 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -5,000 69,504 -6.71 86.45 -432,250 6,008,621
2019-08-14 2019-08-12 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 5,000 74,504 7.19 3.44 17,200 256,294
2019-07-12 2019-07-10 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,000 24,743 -16.81
2019-07-12 2019-07-10 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -5,000 69,504 -6.71 64.83 -324,155 4,506,014
2019-07-12 2019-07-10 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 5,000 74,504 7.19 3.44 17,200 256,294
2019-06-21 2019-06-19 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -25,000 29,743 -45.67
2019-06-21 2019-06-19 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -25,000 69,504 -26.45 60.02 -1,500,500 4,171,630
2019-06-21 2019-06-19 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 25,000 94,504 35.97 3.44 86,000 325,094
2019-06-12 2019-06-10 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,000 54,743 -8.37
2019-06-12 2019-06-10 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -100 69,504 -0.14 55.60 -5,560 3,864,422
2019-06-12 2019-06-10 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -4,900 69,604 -6.58 55.04 -269,706 3,831,143
2019-06-12 2019-06-10 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 5,000 74,504 7.19 3.44 17,200 256,294
2019-05-24 2019-05-22 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
A - Award 6,340 6,340
2019-05-24 2019-05-22 4 NVCR NovoCure Ltd
Restricted Stock Units
A - Award 3,359 69,504 5.08
2019-05-22 2019-05-21 4 NVCR NovoCure Ltd
Restricted Stock Units
M - Exercise -6,145 0 -100.00
2019-05-22 2019-05-21 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 6,145 66,145 10.24 48.87 300,306 3,232,506
2019-05-14 2019-05-10 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,000 59,743 -7.72
2019-05-14 2019-05-10 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -5,000 60,000 -7.69 49.79 -248,950 2,987,400
2019-05-14 2019-05-10 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 5,000 65,000 8.33 3.44 17,200 223,600
2019-04-12 2019-04-10 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,000 64,743 -7.17
2019-04-12 2019-04-10 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -5,000 60,000 -7.69 45.95 -229,750 2,757,000
2019-04-12 2019-04-10 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 5,000 65,000 8.33 3.44 17,200 223,600
2019-03-12 2019-03-11 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,000 69,743 -6.69
2019-03-12 2019-03-11 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -5,000 60,000 -7.69 48.31 -241,550 2,898,600
2019-03-12 2019-03-11 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 5,000 65,000 8.33 3.44 17,200 223,600
2019-03-04 2019-03-01 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -25,000 74,743 -25.06
2019-03-04 2019-03-01 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -25,000 60,000 -29.41 55.01 -1,375,275 3,300,660
2019-03-04 2019-03-01 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 25,000 85,000 41.67 3.44 86,000 292,400
2019-02-13 2019-02-11 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,000 99,743 -4.77
2019-02-13 2019-02-11 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -5,000 60,000 -7.69 49.59 -247,950 2,975,400
2019-02-13 2019-02-11 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 5,000 65,000 8.33 3.44 17,200 223,600
2019-01-28 2019-01-25 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -20,000 104,743 -16.03
2019-01-28 2019-01-25 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -20,000 60,000 -25.00 50.00 -1,000,000 3,000,000
2019-01-28 2019-01-25 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 20,000 80,000 33.33 3.44 68,800 275,200
2019-01-18 2019-01-16 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -20,000 124,743 -13.82
2019-01-18 2019-01-16 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -20,000 60,000 -25.00 45.00 -900,060 2,700,180
2019-01-18 2019-01-16 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise X 20,000 80,000 33.33 3.44 68,800 275,200
2019-01-14 2019-01-10 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise -5,000 144,743 -3.34
2019-01-14 2019-01-10 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -5,000 60,000 -7.69 39.91 -199,550 2,394,600
2019-01-14 2019-01-10 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 5,000 65,000 8.33 3.44 17,200 223,600
2019-01-11 2019-01-09 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise 20,000 149,743 15.42
2019-01-11 2019-01-09 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -6,726 60,000 -10.08 40.01 -269,107 2,400,600
2019-01-11 2019-01-09 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale -13,274 66,726 -16.59 40.00 -530,960 2,669,040
2019-01-11 2019-01-09 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 20,000 80,000 33.33 3.44 68,800 275,200
2018-12-12 2018-12-10 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
M - Exercise 5,000 169,743 3.04
2018-12-12 2018-12-10 4 NVCR NovoCure Ltd
Ordinary Shares
S - Sale X -5,000 60,000 -7.69 33.49 -167,450 2,009,400
2018-12-12 2018-12-10 4 NVCR NovoCure Ltd
Ordinary Shares
M - Exercise 5,000 65,000 8.33 3.44 17,200 223,600
2018-06-04 2018-05-31 4 NVCR NovoCure Ltd
Restricted Stock Unit
A - Award 6,145 6,145
2018-06-04 2018-05-31 4 NVCR NovoCure Ltd
Options to Buy Ordinary Shares
A - Award 12,345 12,345
2018-05-23 2018-05-22 4 PTX PERNIX THERAPEUTICS HOLDINGS, INC.
Stock Option (right to buy)
A - Award 25,000 25,000
2018-05-17 2018-05-16 4 NVCR Novocure Ltd
Options to Buy Ordinary Shares
M - Exercise 100,000 174,743 133.79
2018-05-17 2018-05-16 4 NVCR Novocure Ltd
Ordinary Shares
S - Sale -40,000 60,000 -40.00 28.77 -1,150,800 1,726,200
2018-05-17 2018-05-16 4 NVCR Novocure Ltd
Ordinary Shares
M - Exercise 100,000 100,000 3.44 344,000 344,000
2018-05-17 2018-05-15 4 NVCR Novocure Ltd
Options to Buy Ordinary Shares
M - Exercise 40,000 274,743 17.04
2018-05-17 2018-05-15 4 NVCR Novocure Ltd
Ordinary Shares
S - Sale -40,000 0 -100.00 28.88 -1,155,200
2018-05-17 2018-05-15 4 NVCR Novocure Ltd
Ordinary Shares
M - Exercise 40,000 40,000 3.44 137,600 137,600
2017-11-17 2017-11-15 4 PTX PERNIX THERAPEUTICS HOLDINGS, INC.
Stock Option (right to buy)
A - Award 50,000 50,000
2016-11-22 2016-11-21 4 PTX PERNIX THERAPEUTICS HOLDINGS, INC.
Stock Option (right to buy)
A - Award 4,000 4,000
2016-11-22 3 PTX PERNIX THERAPEUTICS HOLDINGS, INC.
No securities are beneficially owned.
0
2015-03-04 2015-03-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
A - Award 6,881 6,881 17.05 117,321 117,321
2015-03-04 2015-03-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 2,639 31,316 9.20 17.05 44,995 533,938
2014-07-09 2014-07-07 4 DCTH DELCATH SYSTEMS, INC.
Common Stock
A - Award 14,424 21,485 204.28
2014-02-06 2014-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock
A - Award 7,201 7,201 10.43 75,106 75,106
2014-02-06 2014-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 3,356 28,677 13.25 10.43 35,003 299,101
2013-11-01 2013-11-01 4 DCTH DELCATH SYSTEMS, INC.
Common Stock
A - Award 16,500 98,027 20.24
2013-06-07 2013-06-05 4 DCTH DELCATH SYSTEMS, INC.
Common Stock
A - Award 33,000 81,527 68.00
2013-02-04 2013-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock
A - Award 12,367 12,367 5.99 74,078 74,078
2013-02-04 2013-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 5,843 25,321 30.00 5.99 35,000 151,673
2012-06-19 2012-06-15 4 DCTH DELCATH SYSTEMS INC
Common Stock
A - Award 32,680 48,527 206.22
2012-06-18 2012-06-15 4 DCTH DELCATH SYSTEMS INC
Common Stock
P - Purchase 7,500 15,847 89.85 1.57 11,762 24,851
2012-06-14 2012-06-13 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock
A - Award 10,000 10,000 2.59 25,900 25,900
2012-06-07 2012-06-06 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 6,224 19,478 46.96 2.41 15,000 46,942
2011-03-31 3 DCTH DELCATH SYSTEMS INC
No securities are beneficially owned.
0
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)